1-20 of 16561 Search Results for

tumor-microenvironment

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 5602.
Published: 15 June 2022
...Igor Feldman; Tatiana Novobrantseva; Ani Nguyen; Jessica Ritter; Mohammad Zafari; Denise Manfra; Susan Low; Steve Sazinsky; Michael Brehm; Boris Klebanov Suppressive myeloid cells in the tumor microenvironment (TME) are associated with poor survival of cancer patients and resistance to T cell...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 5419.
Published: 15 June 2022
... Marchio. A unique pattern of heterogeneous MMR protein expression in colorectal cancer unveils different degrees of tumor mutational burden and distinct tumor microenvironment features [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 2127.
Published: 15 June 2022
..., network-based approach to identify top MR proteins by utilizing a combination of ARACNe (Margolin et al, 2006) and VIPER (Alvarez et al, 2016) algorithms for the analysis of single-nuclei transcriptomic data. Specifically, we used VIPER to investigate the heterogeneity of the tumor microenvironment (TME...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 3188.
Published: 15 June 2022
... in EOC is driven by the survival of chemoresistant, stem-like tumor-initiating cells (TICs) that are supported by a complex extracellular matrix (ECM) and immunosuppressive microenvironment. To target TICs to prevent recurrence, we identified genes critical for TIC viability from a whole genome siRNA...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 2558.
Published: 15 June 2022
... independence. RT-PCR and western blot analyses demonstrated significantly higher RBM3 levels in C4-2B cells as compared to LNCaP cells suggesting a role for RBM3 in tumor progression. The tumor microenvironment also plays a very important role in prognosis of PCa. Specifically, tumor-associated macrophages...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 3420.
Published: 15 June 2022
... that modifies anti-tumor responses to anti-PD-1 immunotherapy through its action on the tumor microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3420. ©2022 American...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 239.
Published: 15 June 2022
... with fresh patient tumor samples we assessed the therapeutic efficacy of Entinostat with intact stromal components and tumor immune microenvironment. Methods: All tumor samples were obtained with patient consent and relevant IRB approval. Unpropagated 3D tumoroids with intact TME measuring 150 µm in size...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 6164.
Published: 15 June 2022
.... Antonescu; Ming Li; Liang Deng; Yu Chen; Ping Chi Immune checkpoint blockade (ICB) has demonstrated clinical success in “inflamed” tumors with significant T-cell infiltrates, but tumors with an immune-desert tumor microenvironment (TME) fail to benefit. The tumor cell-intrinsic molecular mechanisms...
Journal Articles
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 247.
Published: 15 June 2022
... therapeutic avenue. To establish the role of Notch4 within the tumor microenvironment, we analyzed its expression in both human and murine tumor samples. Immunofluorescent staining revealed a range of Notch4 expression in both tumor cells and endothelium in human triple negative breast cancers. Several murine...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 1609.
Published: 15 June 2022
... and consequently tumorigenesis in the tumor microenvironment. Recently, our group has developed a spinal cord glioma (SCG) model in Göttingen minipigs. However, the mechanism of how SCGs balance redox and thereby modulate cellular proliferation is unclear. Here, we demonstrated that the NRF2/NQO1 signaling, known...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 1719.
Published: 15 June 2022
...Kouther Noureddine; Paul Gallagher; Martial Guillaud; Calum MacAulay The tumor microenvironment (TME) is a highly complex mixture containing epithelium, stroma and a diverse network of immune cells & the spatial organization of these immune cells within the TME reflects a crucial process...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 5269.
Published: 15 June 2022
... treatment. To optimally stratify patients for such strategy, reliable and preferably non-invasive biomarkers that repeatedly can assess neoadjuvant therapy response are needed. Recognizing the importance of the tumor microenvironment, we investigated a less explored imaging marker assessing tumor BF for its...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 5486.
Published: 15 June 2022
... associated molecular patterns, e.g. damaged genomic DNA, released from injured cancer cells can be converted into 2’, 3’-cGAMP by cGAS. Subsequently, cGAMP triggers STING pathway activation to produce type I interferons (IFNs) and other related innate immunity in the tumor microenvironment. Ecto-nucleotide...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 2636.
Published: 15 June 2022
... suppression and resistance to therapy is orchestrated by the presence and activity of stromal cells in the tumor microenvironment. Therefore novel approaches to overcome stromal mediated resistance to therapy represent a potential strategy to improve the outcome to chemotherapy and immune checkpoint blockade...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 6354.
Published: 15 June 2022
... of patients. To understand the complex tumor immune microenvironment (TiME) and immune responses in patients before and after this treatment, we used imaging mass cytometry (IMC) to perform single cell, highly multiplexed, analysis of these patients’ bone marrow samples. Methods: We comprehensively...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 2548.
Published: 15 June 2022
...; Ben Freiberg; C. David James; Leonidas C. Platanias; Maciej S. Lesniak; Jared K. Burks; Amy B. Heimberger Introduction: Deconstructive immune cell profiling of central nervous system (CNS) tumors has focused on the tumor, excluding interrogation of the tumor microenvironment (TME). Integrated spatial...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 2550.
Published: 15 June 2022
... Santagata, Giuseppina Rea, Maria Napolitano, Crescenzo D'Alterio, Rita Guarino, Vittorio Albino, Andrea Belli, Carmen Cutolo, Francesco Izzo, Stefania Scala. Tumor microenvironment (TME) is more suppressive in hepatocellular carcinoma (HCC) than in colorectal cancer liver metastasis (CRLM): CXCR4 antagonism...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 6101.
Published: 15 June 2022
... co-cultured with K6-K14/V7-expressing OSCC cells can be converted into a pro-inflammatory type of cancer-associated fibroblasts (iCAFs). Those findings suggest the ability of K6-K14/V7-expressing OSCC cells in remodeling tumor microenvironment. In this study, we will discuss how K6-K14/V7-expressing...
Journal Articles
Cancer Res (2022) 82 (12_Supplement): 6108.
Published: 15 June 2022
... in patient tumors due to the lack of the tumor microenvironment. The primary objective of this study was to perform functional genomic screens in in vivo models to identify clinically relevant epigenetic vulnerabilities. METHODS: We designed an EpiDrug sgRNA library that target 357 epigenetic regulators...